QQ客服 官方微博 反馈留言

	Discovery and optimization of 1-(1H-indol-1-yl)ethanone derivatives as CBP/EP300 bromodomain inhibitors for the treatment of castration-resistant prostate cancer
	Xiang, Qiuping[1]; Wang, Chao[1,3]; Zhang, Yan[1]; Xue, Xiaoqian[1]; Song, Ming[1]; Zhang, Cheng[1,3]; Li, Chenchang[1,3]; Wu, Chun[1]; Li, Kuai[1]; Hui, Xiaoyan[2,4]
	2018
卷号	147页码:238
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4461264
专题	暨南大学
作者单位	1.[1]Guangzhou Med Univ, Guangdong Prov Key Lab Biocomp, Joint Sch Life Sci, Chinese Acad Sci,Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China 2.[2]Univ Chinese Acad Sci, 19 Yuquan Rd, Beijing 100049, Peoples R China 3.[3]Jilin Univ, Sch Pharmaceut Sci, 1266 Fujin Rd, Changchun 130021, Jilin, Peoples R China 4.[4]Univ Hong Kong, Dept Med, State Key Lab Pharmaceut Biotechnol, Hong Kong, Hong Kong, Peoples R China 5.[5]Univ Auckland, Auckland Canc Soc, Res Ctr, Sch Med Sci, Private Bag 92019, Auckland, New Zealand 6.[6]Jinan Univ, Sch Pharm, 601 Huangpu Ave West, Guangzhou 510632, Guangdong, Peoples R China
推荐引用方式 GB/T 7714	Xiang, Qiuping[1],Wang, Chao[1,3],Zhang, Yan[1],et al. Discovery and optimization of 1-(1H-indol-1-yl)ethanone derivatives as CBP/EP300 bromodomain inhibitors for the treatment of castration-resistant prostate cancer[J],2018,147:238.
APA	Xiang, Qiuping[1].,Wang, Chao[1,3].,Zhang, Yan[1].,Xue, Xiaoqian[1].,Song, Ming[1].,...&Xu, Yong[1].(2018).Discovery and optimization of 1-(1H-indol-1-yl)ethanone derivatives as CBP/EP300 bromodomain inhibitors for the treatment of castration-resistant prostate cancer.,147,238.
MLA	Xiang, Qiuping[1],et al."Discovery and optimization of 1-(1H-indol-1-yl)ethanone derivatives as CBP/EP300 bromodomain inhibitors for the treatment of castration-resistant prostate cancer".147(2018):238.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。